Trial Assessing Ability of Capricor’s Cardiac Cell Therapy, CAP-1002, to Reduce the Cytokine Storm Associated with Severe COVID-19LOS ANGELES, Dec....
SAN MATEO, Calif.--(BUSINESS WIRE)--$modeln--Model N, Inc. (NYSE: MODN), the leader in cloud revenue management solutions, today announced that John Ederer...
CRV431 Demonstrated to be Generally Safe and Well Tolerated Clinically Significant Reductions in Important Biomarkers, ALT and AST, Observed in...
WESTPORT, CT / ACCESSWIRE / December 29, 2020 / CYduct Diagnostics, Inc. (OTC PINK:SNDYD) is pleased to announce that FINRA...
Former Breg Leader To Advance Dynatronics' Business Growth EAGAN, MN / ACCESSWIRE / December 29, 2020 / Dynatronics Corporation (NASDAQ:DYNT),...
LAS VEGAS, NV / ACCESSWIRE / December 29, 2020 / CLS Holdings USA, Inc. (OTCQB:CLSH)(CSE:CLSH): Adaptation 2020 has been a...
- DSMB Review After Completion of the First Dose Cohort Affirmed No Safety or Tolerability Concerns with CRV431 in NASH...
OTTAWA, ON / ACCESSWIRE / December 29, 2020 / Innovative Medicines Canada (IMC) issued the following statement today regarding the...
TORONTO, Dec. 29, 2020 (GLOBE NEWSWIRE) -- Arch Biopartners Inc. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF),...
SAN DIEGO, Dec. 29, 2020 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ: TCON), a clinical stage biopharmaceutical company focused on the...
WARSAW, Ind., Dec. 29, 2020 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company exclusively focused on advancing the...
Following a competitive process, Fulgent was selected to extend its support of the NYC DOE public school testing managed by...
The Company continues expansion of its lumateperone programs with the advancement of a Long-Acting injectable formulation into clinical trials. ITI-333...
NEW YORK, Dec. 29, 2020 (GLOBE NEWSWIRE) -- BeyondSpring (the “Company” or “BeyondSpring”) (NASDAQ: BYSI), a global biopharmaceutical company focused...
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES HALIFAX, Nova Scotia, Dec. 29, 2020...
MOORESTOWN, N.J., Dec. 29, 2020 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC), today announced CEO, Chairman and Founder, Calvin H. Knowlton, Ph.D.;...
HAIFA, Israel, Dec. 29, 2020 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PSTI), a leading regenerative medicine company developing a...
Expands OVAL Phase 3 Potential Registration Study of VB-111 for the Treatment of Platinum-Resistant Ovarian Cancer into Europe TEL AVIV, Israel, Dec....
● Patent supporting Autosomal Dominant PolycysticKidney Disease Granted – XRx-008 Program ● CALGARY, Alberta, Dec. 29, 2020 (GLOBE NEWSWIRE) --...
Bagsværd, Denmark, 29 December 2020 – Novo Nordisk today announced the submission of a label extension application to the European...